Timothy Warren Paul

Title: The Innovations of Timothy Warren Paul

Introduction

Timothy Warren Paul is a notable inventor based in Bloomington, IN (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates. With a total of 2 patents, his work focuses on creating formulations that enhance the efficacy of therapeutic agents.

Latest Patents

Timothy's latest patents include innovative formulations for antibody and drug conjugates. One patent discloses surfactant-free antibody and antibody-drug-conjugate (ADC) formulations for anti-AXL antibodies and ADCs. These formulations are designed to be particularly suitable for an anti-AXL ADC based on an auristatin or DM1 derivative, as well as other similarly hydrophobic drugs. The formulations often comprise histidine and mannitol, which contribute to their stability and effectiveness. Another patent details surfactant-free lyophilized formulations of antibody-drug conjugates, such as anti-tissue factor ADCs. These formulations are also designed for reconstitution and include excipients like histidine, sucrose, trehalose, mannitol, and glycine.

Career Highlights

Timothy Warren Paul is currently employed at Genmab A/S, where he continues to innovate in the field of antibody-drug conjugates. His work has been instrumental in advancing therapeutic options for various diseases, showcasing his commitment to improving patient outcomes through scientific research.

Collaborations

Timothy collaborates with talented professionals in his field, including Kelly Ann Roby and Gregory Allan Sacha. Their combined expertise contributes to the success of their projects and the development of groundbreaking therapies.

Conclusion

Timothy Warren Paul's contributions to biotechnology through his patents and work at Genmab A/S highlight his role as a leading inventor in the field. His innovative formulations for antibody-drug conjugates are paving the way for more effective treatments.